“When Olympism rhymes with Galenism: there is a gold medal which can be won on account of outperformance: it is the prix Galien, this academy award of pharmaceutical research.”

— Walter SUTER, State Councilor, Director of Public Economy

Contact: Petra GENETZKY


Winners 2019:

Jardiance (Boehringer-Ingelheim, category: primary & specialty)

RYDAPT (Novartis, category: cancer)

Spinraza (Biogen, category: orphan diseases)

For acomprehensivelist ofpast winnersvisit ourHall of Fame

From national and world leaders to shining lights within the pharmaceutical industries, many have offered praise for the Prix Galien.